An international working group within the European LeukemiaNet gathered, aiming to determine the role of flow cytometry (FC) in myelodysplastic syndromes (MDS). It was agreed that FC has a substantial application in disease characterization, diagnosis and prognosis. FC may also be useful in predicting treatment responses and monitoring novel and standard therapeutic regimens. In this article the rationale is discussed that flow cytometry should be integrated as a part of diagnostic and prognostic scoring systems in MDS. © 2013 Informa UK, Ltd.

Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: Position paper of an International Consortium and the European LeukemiaNet Working Group / Van De Loosdrecht, A. A.; Ireland, R.; Kern, W.; Della Porta, M. G.; Alhan, C.; Balleisen, J. S.; Bettelheim, P.; Bowen, D. T.; Burbury, K.; Eidenschink, L.; Cazzola, M.; Chu, S. S. C.; Cullen, M.; Cutler, J. A.; Drager, A. M.; Feuillard, J.; Fenaux, P.; Font, P.; Germing, U.; Haase, D.; Hellstrom-Lindberg, E.; Johansson, U.; Kordasti, S.; Loken, M. R.; Malcovati, L.; Te Marvelde, J. G.; Matarraz, S.; Milne, T.; Moshaver, B.; Mufti, G. J.; Nikolova, V.; Ogata, K.; Oelschlaegel, U.; Orfao, A.; Ossenkoppele, G. J.; Porwit, A.; Platzbecker, U.; Preijers, F.; Psarra, K.; Richards, S. J.; Subira, D.; Seymour, J. F.; Tindell, V.; Vallespi, T.; Valent, P.; Van Der Velden, V. H. J.; Wells, D. A.; De Witte, T. M.; Zettl, F.; Bene, M. C.; Westers, T. M.. - In: LEUKEMIA & LYMPHOMA. - ISSN 1042-8194. - 54:3(2013), pp. 472-475. [10.3109/10428194.2012.718341]

Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: Position paper of an International Consortium and the European LeukemiaNet Working Group

Kordasti S.
Membro del Collaboration Group
;
2013-01-01

Abstract

An international working group within the European LeukemiaNet gathered, aiming to determine the role of flow cytometry (FC) in myelodysplastic syndromes (MDS). It was agreed that FC has a substantial application in disease characterization, diagnosis and prognosis. FC may also be useful in predicting treatment responses and monitoring novel and standard therapeutic regimens. In this article the rationale is discussed that flow cytometry should be integrated as a part of diagnostic and prognostic scoring systems in MDS. © 2013 Informa UK, Ltd.
2013
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11566/328540
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 62
  • ???jsp.display-item.citation.isi??? 52
social impact